C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002	US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002	US6482922 Mammary transforming protein
11/19/2002	US6482919 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/19/2002	US6482807 LPS with reduced toxicity from genetically modified gram negative bacteria
11/19/2002	US6482804 Compositions and methods for delivery of genetic material
11/19/2002	US6482803 Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
11/19/2002	US6482798 Aprotinin variants having a net charge of +3 to -3 at ph 7 and with the amino acids arg15 or arg15-ala17 in the binding region; serine protease inhibitor
11/19/2002	US6482647 Evolving susceptibility of cellular receptors to viral infection by recursive recombination
11/19/2002	US6482646 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators
11/19/2002	US6482644 Antisense modulation of dual specific phosphatase 8 expression
11/19/2002	US6482640 Hybridization device, case, support, and label agent
11/19/2002	US6482638 Heat-relaxable substrates and arrays
11/19/2002	US6482635 Method of reducing off-flavor in water or aquatic life forms using Bacterium NRRL B-30043
11/19/2002	US6482634 Methods and vector constructs useful for production of recombinant AAV
11/19/2002	US6482633 Accessory functions for use in recombinant AAV virion production
11/19/2002	US6482631 Polynucleotides encoding indole-3-gylcerol phosphate synthase from soybean
11/19/2002	US6482630 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
11/19/2002	US6482628 Multiply-substituted protease variants
11/19/2002	US6482626 Human DNase
11/19/2002	US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482621 Compositions and methods for fumonisin detoxification
11/19/2002	US6482619 Cell/tissue analysis via controlled electroporation
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482617 Viable contaminant particle free adenoviruses, their preparation and use
11/19/2002	US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002	US6482614 Stress proteins and uses therefor
11/19/2002	US6482613 Microbial production of mature human leukocyte interferons
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482611 Human capsaicin receptor and uses thereof
11/19/2002	US6482610 Method for producing agents for treating tumor diseases and for immunosuppression
11/19/2002	US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002	US6482607 Expression vector for use in a one-step purification protocol
11/19/2002	US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
11/19/2002	US6482598 Antibody recognizing a small subset of human hematopoietic cells
11/19/2002	US6482595 Methods for detecting mutations using primer extension
11/19/2002	US6482594 Made by exposing nucleic acid candidate sequences having photoreactive groups to the target molecule, irradiating complexes formed to crosslink, and separating the crosslinked complexes and amplifying to give the ligands
11/19/2002	US6482592 Methods and kits for isolating primer extension products using modular oligonucleotides
11/19/2002	US6482591 Libraries of unimolecular, double-stranded oligonucleotides on solid support, useful in screening procedures associated with drug discovery and diagnosis
11/19/2002	US6482586 Hybrid compositions for intracellular targeting
11/19/2002	US6482416 Alteration of macrophage-induced t cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility;
11/19/2002	US6482414 Cold-adapted equine influenza viruses
11/19/2002	US6482412 Actinomyces used to biosynthesize polypeptide to treat aids
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	US6482408 Fibroblast growth factor 15 antibodies
11/19/2002	US6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same
11/19/2002	US6482404 Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2232709C Method for isolating xylanase gene sequences from soil dna, compositions useful in such method and compositions obtained thereby
11/19/2002	CA2199938C Probe for diagnosing infectious diseases
11/19/2002	CA2156512C Treatment of androgen-associated baldness using antisense oligomers
11/19/2002	CA2135073C Nucleic acid sequence amplification method, composition and kit
11/19/2002	CA2108358C Gene expression in bacilli
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2040793C Plasmids expressing patatin and adp-glucose-pyrophosphorylase sequences
11/19/2002	CA1341400C Process for preparing proteins
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/19/2002	CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/18/2002	CA2383745A1 Nucleic acids for detecting dechlorination bacteria and uses thereof
11/15/2002	WO2001088149A1 Polypeptides cleaving telomeric repeats
11/15/2002	CA2410974A1 Polypeptides cleaving telomeric repeats
11/14/2002	WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	WO2002090993A2 Functional protein expression for rapid cell-free phenotyping
11/14/2002	WO2002090992A2 Screening method
11/14/2002	WO2002090986A1 Colon cancer antigen panel
11/14/2002	WO2002090978A1 Method and apparatus for high-speed approximate sub-string searches
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090934A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
11/14/2002	WO2002090926A2 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090594A1 Antisense modulation of phospholipase a2, group vi (ca2+-independent) expression
11/14/2002	WO2002090591A1 Antisense modulation of interleukin 12 p40 subunit expression
11/14/2002	WO2002090590A1 Antisense modulation of interleukin 12 p35 subunit expression
11/14/2002	WO2002090587A1 Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same
11/14/2002	WO2002090586A2 Analytical method and kit
11/14/2002	WO2002090585A2 Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
11/14/2002	WO2002090584A2 Method for labelling and fragmenting dna
11/14/2002	WO2002090583A2 Skin treatment
11/14/2002	WO2002090570A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090566A2 Recombinant tumor specific antibody and use thereof
11/14/2002	WO2002090565A2 Magnetic beads and uses thereof
11/14/2002	WO2002090563A1 Methods for the reduction of stutter in microsatellite amplification using sorbitol
11/14/2002	WO2002090562A2 Methods for the reduction of stutter in microsatellite amplification
11/14/2002	WO2002090558A1 Novel expression vectors and uses thereof
11/14/2002	WO2002090557A2 Freeze-tolerant eukaryotic cells
11/14/2002	WO2002090556A1 Method for targeted homologous gene replacement in kinetoplastidae
11/14/2002	WO2002090555A1 A method for transfection of rna using electrical pulses
11/14/2002	WO2002090554A1 Cloning vector
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090552A2 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
11/14/2002	WO2002090551A2 Self-containing lactococcus strain
11/14/2002	WO2002090550A2 Method for preparing recombinant poxvirus
11/14/2002	WO2002090549A2 Compositions and methods for the modulation of viral maturation
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090547A1 Modification of plant and seed development and plant responses to stresses and stimuli
11/14/2002	WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof

1 ... 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 ... 4023